Evidence map›Paper›PMID 36401638›Full record

ArticleAnalytical and bioanalytical chemistry2023

Analysis of complex drugs by comprehensive two-dimensional gas chromatography and high-resolution mass spectrometry: detailed chemical description of the active pharmaceutical ingredient sodium bituminosulfonate and its process intermediates.

Lukas Schwalb, Ole Tiemann, Uwe Käfer, Thomas Gröger, Christopher Paul Rüger, Guido Gayko, Ralf Zimmermann

Open access · hybridAbstract read
In one paragraph

Article in Analytical and bioanalytical chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Lukas SchwalbJoint Mass Spectrometry Centre (JMSC), Chair of Analytical Chemistry, University of Rostock, Rostock, Germany.
Ole TiemannJoint Mass Spectrometry Centre (JMSC), Chair of Analytical Chemistry, University of Rostock, Rostock, Germany.
Uwe KäferJoint Mass Spectrometry Centre (JMSC), Chair of Analytical Chemistry, University of Rostock, Rostock, Germany.
Thomas GrögerJoint Mass Spectrometry Centre (JMSC), Cooperation Group "Comprehensive Molecular Analytics" (CMA), Helmholtz Zentrum München GmbH, German Research Center for Environmental Health, Neuherberg, Germany. thomas.groeger@helmholtz-muenchen.de.
Christopher Paul RügerJoint Mass Spectrometry Centre (JMSC), Chair of Analytical Chemistry, University of Rostock, Rostock, Germany.
Guido GaykoIchthyol-Gesellschaft, Cordes, Hermanni & Co. (GmbH & Co.) KG, Hamburg, Germany.
Ralf ZimmermannJoint Mass Spectrometry Centre (JMSC), Chair of Analytical Chemistry, University of Rostock, Rostock, Germany.
University of Rostock · DEHelmholtz Zentrum München · DELeibniz Institute for Tropospheric Research · DE

Funding

ICHTHYOL-GESELLSCHAFT Cordes, Hermanni & Co. (GmbH & Co.) KG Industrial Funding
6 · The paper itself

Abstract

The European pharmacopeia provides analytical methods for the chemical characterization of active pharmaceutical ingredients (APIs). However, the complexity of some APIs exceeds the limitations of the currently prevailing physicochemical methods. Sodium bituminosulfonate (SBS) is described by the collection of key parameters of generalizing criteria such as dry matter, sulfur and sodium content, and neutrality, but techniques to unravel the complexity on a molecular level are lacking. We present a study based on online derivatization with tetramethylammonium hydroxide in combination with comprehensive two-dimensional gas chromatography coupled to an electron ionization high-resolution time-of-flight mass spectrometer (GC × GC-HR-ToF-MS) for the chemical description of SBS as well as its process intermediates. The application of GC × GC allowed the comprehensive description of the chemical components in the API and the process intermediates for the first time. Furthermore, it was possible to classify peaks regarding their elemental and structural composition based on accurate mass information, elution behavior, and mass fragmentation pattern. This work demonstrates not only the general applicability, advantages but also limitations of GC × GC for the characterization of APIs for complex drugs.

Indexed as

Mass SpectrometryGas Chromatography-Mass SpectrometryPharmaceutical PreparationsPharmaceutical PreparationsClassificationComplex drugsGC × GCHR-MSNon-biological complex drugsSodium bituminosulfonate

Identifiers

PMID36401638
PMCPMC10149445
OpenAlexW4309409000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.